Insulin Levels Early in Perimenopause Inform Vasomotor Symptom Incidence Across the Menopausal Transition - Takeaways - MDSpire

Insulin Levels Early in Perimenopause Inform Vasomotor Symptom Incidence Across the Menopausal Transition

  • By

  • Faria Athar

  • Sarah Gregory

  • Emma J Houston

  • Nicole M Templeman

  • January 3, 2026

  • 0 min

Share

  • 1

    Elevated insulin levels at age 47 predict earlier onset and prolonged duration of vasomotor symptoms during the menopausal transition.

  • 2

    The study analyzed data from 704 women in the SWAN study, focusing on metabolic health and its impact on menopausal symptoms.

  • 3

    Higher body mass index (BMI) is associated with vasomotor symptoms, but insulin levels show distinct and complementary associations.

  • 4

    Insulin levels at age 47 are linked to increased likelihood of hot flashes, independent of BMI and glucose levels.

  • 5

    The findings suggest that metabolic health, particularly insulin levels, plays a significant role in the menopausal transition.

Original Source(s)

Insulin Levels Early in Perimenopause Inform Vasomotor Symptom Incidence Across the Menopausal Transition

  • by Faria Athar, Sarah Gregory, Emma J Houston, Nicole M Templeman

  • January 3, 2026

Related Content

Adipose–muscle crosstalk during the menopausal transition: mechanistic links to sarcopenic obesity in midlife women

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

Retrospective Analysis of Kampo Medicine's Role in Mitigating Endocrine Therapy Side Effects in Breast Cancer Patients: A Pilot Investigation